The vertebrate-conserved RNA-binding protein DND1 is required for the survival of primordial germ cells (PGCs), as well as the suppression of germ cell tumours in mice [1][2][3][4][5] . Here we show that in mice DND1 binds a UU(A/U) trinucleotide motif predominantly in the 3′ untranslated regions of mRNA, and destabilizes target mRNAs through direct recruitment of the CCR4-NOT deadenylase complex. Transcriptomic analysis reveals that the extent of suppression is dependent on the number of DND1-binding sites. This DND1-dependent mRNA destabilization is required for the survival of mouse PGCs and spermatogonial stem cells by suppressing apoptosis. The spectrum of target RNAs includes positive regulators of apoptosis and inflammation, and modulators of signalling pathways that regulate stem-cell pluripotency, including the TGFβ superfamily, all of which are aberrantly elevated in DND1-deficient PGCs. We propose that the induction of the post-transcriptional suppressor DND1 synergizes with concurrent transcriptional changes to ensure precise developmental transitions during cellular differentiation and maintenance of the germ line.
) results in a substantial loss of PGCs at around E8.5, male sterility, and a high incidence of germ cell tumours (TGCTs) in 129/Sv mice [1] [2] [3] [4] [5] . Dnd1 encodes a vertebrate-conserved RNA-binding protein with a single RNA recognition motif (Extended Data Fig. 1d-f ). It has been proposed that DND1 counteracts miRNA-guided mRNA destabilization on the basis of the observation that DND1 blocked the recruitment of miRNA/AGO complexes to vicinal miRNA target sites in the 3′ untranslated region (UTR) of zebrafish and human CDKN1B (ref. 8). By contrast, another study identified DND1 as a cofactor of NANOS2-mediated gene repression 9 .
To investigate the molecular function of the DND1 protein, we generated stable HEK293 cells expressing doxycycline (Dox)-inducible Flag-and haemagglutinin (HA)-tagged DND1 (FH-DND1) (Extended Data Fig. 1g ). These cells did not express endogenous DND1, and 24 h after Dox addition FH-DND1 protein accumulated to levels similar to that of endogenous DND1 in murine germline stem cells (GSCs), an in vitro counterpart of spermatogonial stem cells (SSCs) 10 (approximately 2.3 × 10 6 versus 1.4 × 10 6 molecules per cell, Extended Data Fig. 1g-m) . Photo-activable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) 11 in these cells yielded a single ribonucleoprotein band at the expected 45 kDa molecular mass (Fig. 1a) . Recovered RNA from three PAR-CLIP experiments was deep-sequenced (Supplementary Table 1 ) and genome-aligned reads were grouped into clusters by PARalyzer 12 to identify those enriched for crosslink-induced T-to-C conversions. We identified 60,310 clusters, referred to as binding sites, of which 78% were mapped to 8,837 distinct mRNAs (Supplementary Table 1 The RNA recognition element of DND1 is contained within AU-rich elements (AUUUA) that are established to influence mRNA half-life by recruitment of proteins that bind to these elements, such as ELAVL1 and ZFP36 (ref. 13) (Extended Data Fig. 2e, f) . We therefore investigated the influence of DND1 on target mRNA stability upon DND1 induction in HEK293 cells using RNA-seq and found significantly reduced levels of target mRNA (Supplementary Table 1 ). This reduction was dependent on the number of DND1-binding sites and the number of crosslinked reads per target mRNA relative to its overall mRNA abundance (normalized crosslinked reads per million, NXPM). Targets with ≥ 20 sites were on average around five times more destabilized than targets with 1-4 binding sites (1.27-fold versus 1.05-fold median reduction in target mRNA abundance; Fig. 1e ). Similarly, mRNAs with ≥ 15 NXPM were on average around ten times more destabilized than targets with < 1 NXPM (1.20-fold versus 1.02-fold median reduction; Fig. 1f ). Only binding sites located in the 3′ UTR contributed to the DND1-mediated target mRNA reduction (Extended Data Figs 2g-i), and it was unaffected by the inhibition of transcription, suggesting post-transcriptional regulation (Extended Data Fig. 2j ).
To elucidate the molecular mechanism of DND1-mediated target repression, we identified interaction partners of DND1 by mass spectrometry of RNase-treated FH-DND1 immunoprecipitates (Extended Data Fig. 3a , b, Supplementary Table 2 ). We detected 6 of the 12 members of the CCR4 complex among the most-enriched proteins (Fig. 2a, Extended Data Fig. 3b, c) . We mapped the vertebrateconserved N-terminal region of the CCR4 scaffolding subunit CNOT1 as the interaction domain with DND1 by using pull-down experiments with GST-tagged CNOT1 variants from FH-DND1 cell lysates (Fig. 2b, Extended Data Fig. 3d , e). This interaction was direct as the GST-CNOT1(1-551) fusion protein also pulled down recombinantly expressed Flag-and His-tagged DND1 (Fig. 2c) . The knockdown of CNOT1 and CNOT7 with short hairpin RNA (shRNA; Extended Data Fig. 3f , Supplementary Table 1) strongly abrogated DND1-mediated repression (Fig. 2d-f) . Furthermore, tethering of a DND1-PP7-coat fusion protein to a reporter RNA containing cognate PP7 hairpin sequences in its 3′ UTR also reduced reporter RNA levels in a CCR4-dependent manner (Extended Data Fig. 3g, h ). Our data suggest that DND1 binding led to target mRNA destabilization by direct recruitment of the CCR4 complex.
Next, we explored the gene-regulatory pathways affected by DND1. Pathway analysis of the top 300 DND1 targets showed enrichment for genes associated with signalling pathways regulating pluripotent stem cells and cancer development (for example, TGFβ , WNT and PI3K-AKT signalling) (Extended Data Fig. 4, Supplementary Table 3 ). The precise regulation of TGFβ levels and suppression of pluripotency genes are also critical for subsequent male differentiation in the gonad. A signal imbalance leads to male infertility and is correlated with TGCT formation 14 , that is, phenotypes observed for Dnd1 loss-of-function mutants 1 . In order to validate our results in murine Dnd1-expressing PGCs and spermatogonia, we determined DND1 PAR-CLIP targets in mouse by using SNL cells stably expressing FH-DND1 and found that mouse and human DND1 targeted homologous mRNAs and pathways (Spearman's ρ = 0.59) (Extended Data Fig. 5, Supplementary Table 4) . We then determined the mRNA profiles of individual spermatogenic cells from mouse testes using Drop-seq 15 . We obtained the transcriptomes of 187 testicular cells, which included 115 spermatogonia (Fig. 3a , Extended Data Fig. 6a -e, Supplementary Table 5) . t-distributed stochastic neighbour embedding (t-SNE) analysis 16 identified three subtypes of spermatogonia: undifferentiated type-A spermatogonia (Nanos3-positive, 50 cells), differentiating type-A spermatogonia (Kit-positive, 51 cells), and type-B-like spermatogonia (Brca2-high, 14 cells). Undifferentiated spermatogonia exhibited the highest expression of Dnd1, which was reduced in differentiating spermatogonia, and undetectable in more advanced cell types, such as B-like spermatogonia (Fig. 3b) . DND1-target mRNA expression showed an inverse relationship with Dnd1 levels and increased significantly between undifferentiated and differentiating spermatogonia (Fig. 3c ) and even more between undifferentiated and B-like spermatogonia ( Fig. 3d) (1.27-fold and 1.49-fold increase of median mRNA level for the top quartile of targets).
For loss-of-function analyses, we cultured undifferentiated spermatogonia and established murine GSCs 10 . Depletion of Dnd1 by shRNAs resulted in a significant increase in apoptosis and a complete loss of GSCs, indicating its critical role in SSC self-renewal (Fig. 3e , Extended Data Fig. 6f-j) . mRNA profiling in Dnd1-knockdown and control GSCs revealed, as expected, an upregulation of DND1 PAR-CLIP targets upon Dnd1 depletion, including positive regulators of apoptosis (Fig. 3f, Extended Data Fig. 6k, m) . Next, we depleted Cnot1 and Cnot7 in GSCs (Extended Data Fig. 6f ). Analogous to Dnd1-knockdown GSCs, we found a significant loss of Cnot1-knockdown GSCs within 8 days, supporting a critical role of the CCR4 complex in SSC self-renewal (Extended Data Fig. 6n ). CNOT1, CNOT7 and DND1 shared overlapping downstream targets: pairwise comparison of mRNA changes showed a strong correlation between Dnd1-knockdown and Cnot1-knockdown (Pearson's r = 0.73) or Cnot7-knockdown (r = 0.83) (Fig. 3g, h, Extended Data Fig. 6l, o) . Thus, we conclude that both the targets and mechanism of DND1are conserved among vertebrates, and that DND1 is one of the major mRNA-directed proteins engaging the CCR4 complex to regulate the transcriptome of SSCs. Additionally, by competing for access to CCR4, DND1 may temporarily dampen miRNA-guided destabilizing effects, offering an alternative explanation for the previously observed loss of miRNA control of CDKN1B upon DND1 overexpression 8 (Extended Data Fig. 3i ). Next, we investigated the role of DND1 during PGC development, a process previously characterized as a complex interplay of transcriptional and post-transcriptional regulation 17 . We recapitulated PGC specification 18 and induced PGC-like cells (PGCLCs) from embryonic stem cell-derived epiblast-like cells (EpiLCs) in sphere cell cultures. First, we compared the mRNA profiles of EpiLCs with whole spheres consisting of 40-50% PGC precursors at day 2 of the induction course, as well as to sorted PGCLCs at day 4 (Supplementary Table 6 ). The seven-to tenfold induction of Dnd1 expression in day 2 and day 4 PGCLCs (88 and 133 fragments per kilobase of transcript per million mapped reads (FPKM), respectively) was accompanied by the downregulation of DND1 PAR-CLIP targets (Fig. 4a, Extended Data Fig. 7a, b) . This inverse expression pattern of Dnd1 and its target mRNAs was also observed in gene expression profiles from PGC precursors in vivo 19 , further supporting the role of DND1 as a negative regulator of target gene expression (Extended Data Fig. 7c, d, Supplementary Table 7) . Table 5 ). e, Time course counting relative number of GSCs transduced at day 0 with the indicated shRNAs. f, Transcript abundance change of GSCs transduced with either shRNA targeting DND1 (four technical replicates) or a control shRNA (five replicates). g, h, Scatter plot of transcript abundance changes of shDND1 versus shControl and shCNOT1 (three replicates) versus shControl (g) or shCNOT7 (three replicates) versus shControl (h). Colour corresponds to q value (see key). Pearson's r is indicated.
We established three independent Dnd1
-/-embryonic stem cell lines (Extended Data Fig. 7e-g ), all of which were incapable of supporting germline development in vivo (Extended Data Fig. 8a-c) . We induced PGCLCs from these cells and observed that the induction of germ cell genes, including critical factors for PGC development (for example, Prdm1, Prdm14 and Nanos3) in Dnd1 -/-PGCLCs was comparable to wild type despite around a 72% reduction of day 4 Dnd1 -/-PGCLC numbers, which mirrored the approximate 85% loss of PGCs immediately after the successful PGC specification in Dnd1
Ter/Ter embryos 5 (Fig. 4a , Extended Data Figs 8d, e and 9a, b). Transcriptomic analysis of Dnd1 -/-EpiLCs (day 0), day 2 and day 4 PGCLCs revealed, as expected, a significant upregulation of DND1-target mRNAs by day 2 (Fig. 4b , Extended Data Figs 8f and 9c, e, f). We next subdivided DND1-target mRNAs according to whether they were upregulated, downregulated or unchanged in wild-type PGCLCs between days 2 and 4. We observed that Dnd1 loss preferentially affected those DND1-target mRNAs that are also transcriptionally silenced (downregulated) during PGCLC induction (Fig. 4c) . Thus, we propose that, analogous to other post-transcriptional regulators including miRNAs 20 , DND1 helps ensure precise developmental transitions in developing PGCs by clearing mRNAs of genes undergoing parallel transcriptional silencing.
We observed a broad upregulation of functional groups of genes relating to the phenotype triggered by Dnd1 loss, including regulators of apoptosis and inflammation (Extended Data Fig. 9c , it is conceivable that loss of function of DND1 and increased target mRNA abundance may trigger an aberrant nucleic-acid-driven innate response contributing to the inflammatory apoptosis 22 . The activation of transcription of pluripotency genes including Nanog Fig. 9c-g) .
A small group of RBP family proteins, including Piwi-interacting-RNA pathway, DAZ, NANOS and DND1 proteins, are specifically expressed in the germ line 24 and implicated in facilitating RNA turnover [25] [26] [27] [28] [29] . These factors provide specificity for target RNA recognition and recruit and possibly co-activate general RNA turnover complexes to control post-transcriptional gene regulation essential for development and maintenance of the mammalian germ line.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. +/+ and Dnd1 −/− PGCLCs at day 2 (biological duplicates). Binning as in Fig. 3f . c, Box plots of transcript abundance change comparing Dnd1 +/+ and Dnd1 −/− PGCLCs for transcripts with the indicated number of DND1-binding sites at day 2. These groups were further binned according to whether transcripts were silenced (q < 0.05; red box), unchanged (q ≥ 0.05; green box), or upregulated (q < 0.05; blue box) between days 2 and 4 of the PGCLC induction time course in wild-type cells. Supplementary Information is available in the online version of the paper.
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MethOdS
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Microarray. The microarray expression data (139 samples from 6 previous publications 19 , listed in Supplementary Table 9) were downloaded from Gene Expression Omnibus (GEO) and the. cel files were normalized concurrently for all samples using the dChip software 30 . Cell lines and culture conditions. HEK293 T-REx Flp-In cells (Thermo Fisher Scientific) were grown in in Dulbecco's modified Eagle's medium (DMEM) (Thermo Fisher Scientific; cat. no. 11965-118) supplemented with 10% (v/v) fetal bovine serum (FBS) (SIGMA-ALDRICH; cat. no. F4135-500ML), 1× penicillinstreptomycin solution (Thermo Fisher Scientific; cat. no. 15140-122), 100 μ g ml
zeocin (cat. no. ant-zn-5; Invivogen) and 15 μ g ml −1 blasticidin (cat. no. ant-bl-5; Invivogen). Cell lines stably expressing Flag-HA-(FH-)DND1 were generated as described previously 31 and maintained in the same cell culture medium supplemented with 100 μ g ml . PAR-CLIP cDNA libraries were sequenced on an Illumina HiSeq 2500 instrument. Clusters of overlapping reads uniquely mapping to the human genome hg19 and mouse mm10, respectively, were generated using the PARalyzer software 12 allowing for one mismatch and otherwise default settings. Clusters were annotated against Gencode gtf files; human: gencode.v19.chr_patch_hapl_scaff. annotation.gtf; mouse: gencode.vM2.chr_patch_hapl_scaff.annotation.gtf (http://www. gencodegenes.org). Alignment data are also available on https://rnaworld. rockefeller.edu/DND1/. We intersected the two deepest datasets (replicate 1 and 2; Spearman correlation ρ = 0.91; Extended Data Fig. 2a, b) . The shared clusters were defined as 'DND1-binding sites' in our transcriptomic analyses. Tethering assay. For Extended Data Fig. 3g , h, DND1 cDNA was cloned in frame with the sequence coding for the PP7 coat protein into pCMV-PP7 (provided by D. R. Larson and M. Palangat, NCI/NIH). Unaltered pCMV-PP7 was used to adjust the overall amount of plasmid DNA, which was maintained constant across transfection experiments. Plasmid pcTET2 containing β -globin cDNA fused to 4 × PP7 stem loops in its 3′ UTR and was used for doxycycline-inducible expression of the reporter RNA (provided by J. R. Hogg, NHLBI/NIH). Increasing concentrations of pCMV-DND1-PP7 (0, 0.25, 0.75, 1 and 1.5 μ g) were co-transfected with 0.25 μ g of the reporter plasmid using 6 μ l per well Lipofectamine 3000 (Invitrogen) according to the manufacturer's recommendation into HEK293 T-REx cells grown in 12-well plates to 70% confluency. Twenty-four hours after transfection, expression of the reporter RNA was induced by adjusting the culture medium concentration to 0.1 μ g ml −1 doxycycline and further incubated for 24 h. β -Globin mRNA levels were quantified by qPCR using the following primers: forward 5′ -AGCTGCACTGTGACAAGCTG-3′; reverse 5′ -CTGGTGGGGTGAATTCTTTG-3′ and normalized against GAPDH (primers: forward: 5′ -GGAGCGAGATCCCTCCAAAAT-3′; reverse: 5′ -GGCTGTTG TCATACTTCTCATGG-3′). When combined with the depletion of CNOT1 and CNOT7, 0.25 μ g of shRNA expression plasmids (pLKO.1 or pLKO.5; Supplementary Table 9) were first transfected into HEK293 T-REx cells using 6 μ l per well Lipofectamine 3000 (Invitrogen) for 72 h into HEK293 T-REx cells grown in 12-well plates to 70% confluency. After 72 h, cells were split 1:2 before co-transfection of 0.25 μ g shRNA plasmids, 1 μ g of pCMV-DND1-PP7 (or pCMV-PP7 for control), and 0.25 μ g of reporter plasmid using 6 μ l per well Lipofectamine 3000. Twenty-four hours after transfection, expression of the reporter RNA was induced by adjusting the culture medium concentration to 0.1 μ g ml −1 doxycycline and incubated for a further 24 h. Co-immunoprecipitation experiments. FH-DND1 HEK293 cells from one confluent 15-cm plate were lysed in NP40 lysis buffer (50 mM HEPES, pH 7.5, 150 mM KCl, 2 mM MgCl 2 , 1 mM NaF, 0.5% (v/v) NP40, 0.5 mM DTT, complete EDTA-free protease inhibitor cocktail (Roche)) and FH-DND1 immunoprecipitated with anti-Flag-M2 magnetic beads (Sigma-Aldrich, cat. no. M8823) in the presence or absence of 5 U μ l −1 RNase A and 200 U μ l −1 RNase T1 (RNase A/T1 mix, Thermo-Fisher, cat. no. AM2286). Magnetic beads were washed twice with NP40 lysis buffer and the immunoprecipitate eluted with SDS gel loading buffer. Co-immunoprecipitated proteins were detected using western blotting with the following antibodies: anti-DYKDDDDK (Cell Signaling Technology, cat. no. 2368), anti-CNOT1 (Proteintech, cat. no. 14276-1-AP), anti-CNOT6 (Cell Signaling Technology, cat. no. 13415), anti-CNOT7 (Proteintech, cat. no. 14102-1-AP), and anti-TUBA (Cell Signaling Technology, cat. no. 2125). RNA-sequencing. Oligo(dT)-selected RNA was converted into cDNA for RNA sequencing using the Illumina TruSeq RNA Sample Preparation Kit v2 or TruSeq Stranded mRNA Sample Prep Kit according to the instructions of the manufacturer and sequenced on an Illumina HiSeq 2500 or NextSeq 500 platform using 100-or 150-nt single-end sequencing, respectively. For RNA-seq analysis of CNOT1-or CNOT7-depleted FH-DND1 HEK293 cells, the cells were transfected with shRNA expression plasmids by using Lipofectamin 3000 (Thermo Fisher Scientific; cat. no. L3000015), grown with supplementation of 4 μ g ml −1 of puromycin, and harvested 4 days after transfection. Similarly, for RNA-seq analysis of GSCs, the cells were harvested 4 days after lentiviral transduction. Lentivirus. For lentiviral transduction, lentiviral plasmids (pLKO.1 or pLKO.5 for shRNAs; pLVE-FH-EV/mouseDND1-IN for DND1 rescue experiment in GSCs) were prepared or purchased from Sigma-Aldrich as listed in Supplementary Table 9 . Packaging plasmids, psPAX2 and pMD2.G, were provided by D. Trono (Addgene plasmids no. 12260 and no. 12259, respectively). Lentivirus particles were produced by transfecting 293T/17 cells as described elsewhere (https://www.addgene.org/ tools/protocols/pLKO/), concentrated by using Lenti-X Concentrator (Clontech; cat. no. 631231), and suspended in HBSS(+ ). The virus titre was measured by colony formation assay using 293T/17 cells or the Lenti-X GoStix Kit (Clontech; cat. no. 631244). The multiplicity of infection (MOI) was adjusted to approximately 5. Lentivirus-transduced GSCs were selected with 125-500 ng ml −1 puromycin or 200 μ g ml −1 G418 at 2 days after lentiviral transduction. For growth assays, 1.3 × 10 5 GSCs were plated on a 24-well plate. For the cDNA rescue experiment of Dnd1-knockdown GSCs, Flag-HA-tagged mouse DND1 (FH-DND1) was transduced into GSCs using lentiviruses and stable transformants were established by G418 selection. As negative control, a stable transformant with empty vector (FH/EV) was established. shDND1 no. 4, which targets the 3′ UTR of the Dnd1 transcripts, was transduced into all stable transformants to specifically deplete endogenous DND1. Mouse FH-DND1 stable SNL cells were established by using lentiviral vector generated from pLVE-FH-Dnd1-IN (MOI ≈ 5) and maintained with the SNL cell culture medium supplied with 250 μ g ml −1 of Geneticin/ G418 (Thermo Fisher Scientific; cat. no. 10131-035). All cells were routinely authenticated and tested for mycoplasma contamination. Plasmid construction. Plasmid pENTR4 human DND1 (hDND1) was generated by PCR amplification of the respective coding sequences (CDS) followed by restriction digest with SalI and NotI and ligation into pENTR4 (Thermo Fisher Scientific) to create pENTR4-hDND1 (deposited in Addgene; plasmid no. 70070). pENTR4-hDND1 was recombined into pFRT/TO/FLAG/HA-DEST destination plasmid (Thermo Fisher Scientific) using the GATEWAY LR recombinase (Thermo Fisher Scientific).
For efficient induction of transgene expression in GSCs and SNL cells, we modified a lentiviral expression vector by fusing the 3′ UTR sequence of Eef1a1 (ref. 32) to the coding sequence of Dnd1 (data not shown). The DNA sequences of internal ribosome entry site (IRES) and neomycin-resistance gene (neo r ) were PCR-amplified from pLV-tTRKRAB-red (provided by D. Trono (Addgene plasmid no. 12250) 33 ) and pEGFP-N1 (Clonetech), respectively. The mouse Dnd1 coding sequence and 3′ UTR of mouse Eef1a1 (NM_010106.2; 5′-A TA TTACCCCTAACACCTGCCACCCCAGTCTTAATCAGTGGTGGAA GAACGGTCTCAGAACTGTTTGTCTCAATTGGCCATTTAAGTTTAATAGT AAAAGACTGGTTAATGATAACAATGCATCGTAAAACCTTCAGAAGGAA AGAATGTTGTGGACCATTTTTTTTGTGTGTGGCAGTTTTAAGTTATT-3′ ) were cloned by PCR flanked with BamHI sites and EcoRI and KpnI sites, respectively. Then, a BamHI-IRES-neo r (IN)-EcoRI-3′ UTR-of-Eef1a1(E)-KpnI fragment was synthesized by PCR flanked with PspXI-FLAG-HA(FH)-BamHI at the 5′ end. Then, the PspXI-FH-BamHI-IRES-neo r -EcoRI-E-KpnI fragment was subcloned into PspXI and KpnI sites of pLV-tTRKRAB-red to create pLVE-FH-IN (deposited in Addgene; plasmid no. 70071). This plasmid was used as a negative control (FH-only or empty vector). The Dnd1 coding sequence was cloned into the BamHI site of pLVE-FH-IN to create pLVE-FH-Dnd1-IN (deposited in Addgene; plasmid no. 70072).
For knockdown experiments, The RNAi Consortium (TRC) shRNA-expression plasmids were purchased from Sigma-Aldrich as listed in Supplementary Table 9 . For shDND1 expression plasmids, shRNA-coding DNA fragments were synthesized and subcloned into the AgeI and EcoRI sites of the TRC cloning plasmid, pLKO.1 (provided by D. Root; Addgene plasmid no. 10878) 34 to create pLKO.1-shDnd1 #1-#8 (deposited in Addgene; plasmids no. 70058-70060, no. 70065-70069). pLKO.1-scramble shRNA was provided by D. Sabatini (Addgene plasmid no. 1864) 35 .
For preparation of recombinant Flag-and 6 × His-tagged DND1 protein, human DND1 CDS was cloned into NcoI and BamHI sites of pET11d (cat. no. 69439-3;
Letter reSeArCH EMD Millipore) after codon optimization for bacterial expression to create pET11d-FHisDND1 (deposited in Addgene; plasmid no. 70083). Expression plasmids of GST-CNOT1 deletion mutants (pGEX-6P1-CNOT1) were provided by N. Sonenberg 36 . GO and KEGG analysis. Gene Ontology (GO) and KEGG pathway analysis were carried out using the DAVID gene ontology functional annotation tool (https://david.ncifcrf.gov/) 37, 38 with default parameters. We ranked terms according to the P value (also known as EASE score), which is derived from a modified Fisher's exact test. Motif analysis. Motif analysis was carried out using the MEME suite, DREME (http://meme-suite.org/tools/dreme) 39 . We defined a set of top 1,000 clusters from a PAR-CLIP library stringently digested with RNase T1 (replicate 3, an external database for a full list of DND1-binding sites is available at https://rnaworld. rockefeller.edu/DND1/), ranked by number of crosslinked sequence reads and 3′ UTR sequences of non-target mRNAs as control. Animals and stem cell cultures. The Rockefeller University Institutional Animal Care and Use Committee (IACUC) approved all procedures. Timed pregnant mice were purchased from Taconic Farm. Mouse embryonic fibroblasts (MEFs) were derived from E12.5 embryos of ICR mice and maintained in Dulbecco's modified Eagle's medium (DMEM) (Thermo Fisher Scientific; cat. no. 11965-118) supplemented with 10% (v/v) fetal bovine serum (FBS) (Sigma-Aldrich; cat. no. F4135-500ML), 1× penicillin-streptomycin solution (Thermo Fisher Scientific; cat. no. 15140-122;), 1× MEM non-essential amino acids solution (Thermo Fisher Scientific; cat. no. 11140-050), and 1 mM sodium pyruvate (Thermo Fisher Scientific; cat. no. 11360-070). MEFs were treated with 10 μ g ml −1 mitomycin C (Sigma-Aldrich; cat. no. M4287) for 2 h and washed twice with PBS(− ) before using them as feeder cells. Germline stem cells (GSCs) were established from testes of ICR mice at postnatal day (P)3-5 and maintained as described previously 10 on feeder cells. Embryonic stem cells were established from 129/Sv strain of mice (129S6/SvEvTac) as described previously 40 with some modifications; embryonic stem cells (ES cells) were maintained with N2B27/2iLIF medium supplied with 1% knockout serum replacement (KSR) (Thermo Fisher Scientific; cat. no. 10828-010) on cell culture plates coated with 0.1% (w/v) gelatine. ES cell lines were sexed by sex-chromosome-specific PCRs, and male ES cell lines were used in the analyses. Apoptosis assay by using fluorescence-activated cell-sorting (FACS) analysis. shRNA-transduced GSCs were dissociated 3 days after lentiviral transduction as described above, briefly cultured with the complete GSC medium for 15 min, washed with PBS(− ) supplemented with 0.1% BSA (Thermo Fisher Scientific; cat. no. 15260-037), and collected by centrifugation. Annexin V was detected by using FITC Annexin V Apoptosis Detection Kit I (BD Bioschences, cat. no. 556547). Large clumps of cells were removed using a cell strainer (BD Biosciences). Cells were sorted and analysed by flow cytometry (LSR II; BD Biosciences). Chimaera assay. ES cells (129S6/SvEvTac) were transformed with a PiggyBac plasmid carrying a mCherry expression cassette under control of a CAG promoter. To generate chimeric embryos, around 10-15 ES cells were injected into the blastocoel cavity of blastocysts from B6(Cg)-Tyr
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/J (B6 albino) mice. Injected blastocysts were transferred to 2.5-days post coitus pseudo-pregnant females, and the chimeric embryos were harvested at gestational day 12.5 of surrogate mother. The contribution of ES cells in chimaeras was evaluated by eye colour and mCherry expression. CRISPR-Cas9-mediated gene editing for generating Dnd1 mutant ES cells. CRISPR-Cas9-mediated genome editing was performed as described previously 41 . We designed three small guide RNAs (sgRNAs) and used pairs of the sgRNAs 42 for the targeted deletions of RNP-encoding region of Dnd1 loci (Extended Data Fig. 7e ). The following primers were used for the PCR genotyping: sense primer, 5′ -ATCCTTGTGGACCACAGTAACC-3′ ; anti-sense primer, 5′ -GGTTCAAACCACTGAAGGTCATC-3′ . The PCR products were cloned into a pGEM-T Easy plasmid (Promega, cat. no. A1360), and approximately 10 clones per ES cell line were sequenced. The results were further confirmed by RNA-seq analyses (Extended Data Fig. 7b, c) . Induction of EpiLCs and PGCLCs from ES cells. 1.5 × 10 5 cells per well of ES cells were plated on a 12-well plate and induced into EpiLCs for 48 h as described previously 18 . The EpiLCs were then cultured under a floating condition by plating 2-3 × 10 3 cells per well of a 96-well Clear Round Bottom Ultra Low Attachment Microplate (Corning, cat. no. 7007) in GK15 medium supplemented with LIF, BMP4 (500 ng ml ). Day 4 PGCLCs were purified with a fluorescence-activated cell sorter (FACS) (ARIA II; BD Biosciences) by using anti-SSEA1/CD71-eFluor660 (1:20 dilution; eBioscience, cat. no. 50-8813-41) and anti-ITGB3/CD61-PE antibodies (1:200 dilution; BioLegend, cat. no. 104307). Drop-seq of murine spermatogonia from adult testes and data analysis. Germ cells were isolated and purified according to a previously published protocol 43 (Extended Data Fig. 6a, b) . The fraction enriched with spermatogonia was confirmed by quantification of the expression of the surface marker antigen of spermatogonia, EPCAM, using FACS (anti-EPCAM-FITC; fold dilution, 1:100; eBioscience, cat. no. 11-5791-80) (Extended Data Fig. 6c ).
Single-cell sequencing of the spermatogonia-enriched fraction was performed using the Drop-seq method as described previously 15 (Drop-Seq Laboratory Protocol, version 3.1; http://mccarrolllab.com/dropseq/). The amplified cDNA was purified and quantified on TapeStation (Agilent 2200). The cDNA was tagmented and amplified with Nextera XT DNA sample prep kit (Illumina) using P5-SMART and N701 primers. The library was purified, quantified and sequenced on the NextSeq 500 (High-output) platform using custom Read1 primer. The raw data was analysed as described in Drop-seq Core Computational Protocol, version 1.0.1 (http://mccarrolllab.com/dropseq/). Read 2 was trimmed at the 5′ end to remove any adaptor sequence, and the 3′ end was trimmed to remove poly(A) tails of length 6 or greater. These reads were aligned to mouse (mm10) genome using STAR v2.4.2a. Drop-seq tools 1.12 were used to generate the gene expression matrix for downstream clustering analysis.
Using the Seurat package for R (ref. 44) , distinct cell clusters were obtained via PCA and visualized by t-SNE plotting. We first identified the set of genes that was most variable across datasets, after controlling for the relationship between mean expression and variability. We calculated the mean and a dispersion measure (variance divided by mean) for each gene across all 200 single cells, and placed genes into 20 bins based on their average expression. Within each bin, we then z-normalized the dispersion measure of all genes within the bin, in order to identify outlier genes whose expression values were highly variable even when compared to genes with similar average expression. We used a z-score cut-off of 0.7 to identify 447 highly variable genes. In this analysis all genes were evaluated for variability including the presumed ubiquitously expressed genes that were excluded from the previous analysis, which is a potential advantage of this method. We reduced our PCA to 12 significant principal components as previously described and used these principal component loadings as input for t-SNE
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, as implemented in the t-SNE package in R with the 'perplexity' parameter set to 14. This allowed us to differentiate transcriptomes of spermatogonia from post-meiotic cells and somatic cells including round spermatids, peritubular myoid cells, and macrophages (Extended Data Fig. 6d ). We extracted single-cell data of spermatogonia and repeated the above process for further differentiating subtypes of spermatogonia with the same z-score cut-off of 0.7 identifying 308 highly variable genes. We reduced our PCA to two significant component loadings for t-SNE with the perplexity term set to 17. GST pull-down assays. Flag-His-DND1 protein was expressed in E. coli BL21 (DE3) and purified with Ni-NTA agarose (cat. no. 30210; QIAGEN). GST-CNOT1 proteins were expressed and purified as described previously 36, 45 . GST pull-down experiments were performed as described previously 46 . In brief, 5 μ g of each GST protein was immobilized on glutathione sepharose beads and incubated for 16 h at 4 °C with purified Flag-His-DND1 or whole-cell extract prepared from HEK293 cells expressing FHDND1 in buffer C containing 0.1 M KCl and 0.1% NP40 with gentle rocking. After washing three times with buffer C, bound proteins were eluted by boiling beads with Laemmli sample buffer at 98 °C for 5 min. Western blot analysis and antibodies. Proteins were separated on the SDS polyacrylamide gel, blotted onto the Immobilon-P Transfer Membrane, and probed with primary and secondary antibodies by using SNAP i.d. Protein Detection System (cat. no. SNAP2BASE; EMD Millipore). Immunodetection was performed with ECL Select Western Blotting Detection Reagent (cat. no. RPN2235; GE Healthcare). Luminescent signal was detected by a LAS3000 image analyser (Fujifilm). The intensity of each signal was quantified by ImageJ software. The primary antibodies used were as follows: anti-HA mouse monoclonal, cat. no. MMS-101R-500, Covance; anti-Flag M2 mouse monoclonal, cat. no. F3165, Sigma; anti-Flag rabbit polyclonal, cat. no. F7425, Sigma; anti-CNOT7 mouse monoclonal, cat. no. sc-101009, Santa Cruz Biotechnology; anti-CNOT11 (C-6) mouse monoclonal, cat. no. sc-377068, Santa Cruz Biotechnology; anti-TUBA mouse monoclonal, cat. no. T9026, Sigma. The following HRP-conjugated secondary antibodies from DAKO were used: anti-mouse IgG goat polyclonal, cat. no. P0447; anti-rabbit IgG goat polyclonal, cat. no. P0448; anti-goat IgG rabbit polyclonal, cat. no. P0449. Conservation analysis. Conservation analyses were carried out using Clustal Omega (http://www.clustal.org/omega/) [47] [48] [49] . Amino acid sequences retrieved from NCBI database were used in the sequence alignment of DND1 proteins in Extended Data Fig. 1d-f Table 3) . c-h, Genome browser tracks showing 3′ -end portions of representative targets genes involving the KEGG pathway 'Signalling pathways regulating pluripotency of stem cells' . The coverage track from HEK293 and the mapped sequence read from the intersection of the replicates of the FH-DND1 PAR-CLIP experiments are shown. The selected genes were categorized according to the known functions: c, TGFβ receptors; d, NODAL receptors; e, BMP receptors; f, SMAD signal transducers; g, RAS signalling; h, WNT receptor.
